Influenza vaccines market
Influenza Vaccines Market, By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route of Administration (Injection, Nasal Spray), By Age Group (Paediatrics, Adults), By Technology (Egg-Based Flu Vaccines, Cell Culture-Based Flu Vaccines, Recombinant Flu Vaccines), By Distribution Channel (Public, Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI1705
- 197 Pages
- Excel & Pdf
- Biotechnology
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Valency
- Market Snapshot, By Route of Administration
- Market Snapshot, By Age Group
- Market Snapshot, By Technology
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Recent Product Approval/Launches
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Influenza Vaccines Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact on Demand
- Impact on Healthcare
- Epidemiology
- Global Influenza Vaccines Market, By Vaccine Type, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Valency, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Quadrivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Trivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Route of Administration, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Nasal Spray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Age Group, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Technology, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Egg-Based Flu Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Cell Culture-Based Flu Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Recombinant Flu Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Distribution Channel, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2031, (USD BN)
- Introduction
- Global Influenza Vaccines Market, By Region, 2019 – 2031 (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031(%)
- Y-o-Y Growth Analysis, For Regions, 2019 - 2031
- Regional Trends
- North America
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Country, 2019 – 2031 (USD BN)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Country, 2019 – 2031 (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Country, 2019 – 2031 (USD BN)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Country, 2019 – 2031 (USD BN)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Country, 2019 – 2031 (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine Type, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Valency, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Route of Administration, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Age Group, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Technology, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Distribution Channel, 2019 – 2031 (USD BN)
- Market Size and Forecast, By Region/Country, 2019 – 2031 (USD BN)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- CSL Seqirus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FluGen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Moderna, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biocryst Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CPL Biologicals Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CureVac AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OSIVAX
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Solaris Vaccines
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Daiichi Sankyo
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sinovac Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Solaris Vaccines
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Seqirus
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
Segmentation
Market Segmentation
- Vaccine Type:
- Inactivated
- Live Attenuated
- Valency:
- Quadrivalent
- Trivalent
- Route of Administration:
- Injection
- Nasal Spray
- Age Group:
- Pediatrics
- Adults
- Technology:
- Egg-Based Flu Vaccines
- Cell Culture-Based Flu Vaccines
- Recombinant Flu Vaccines
- Distribution Channel:
- Public
- Private
- Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the influenza vaccines market?
The CAGR of the influenza vaccines market is projected to be 7.1% from 2024 to 2031.
What are the major factors driving the influenza vaccines market growth?
Increasing clinical trials for new product development and increasing awareness by government authorities for influenza vaccine are the major factors driving the growth of the influenza vaccines market.
What are the key factors hampering growth of the influenza vaccines market?
High cost of vaccine development and stringent regulations for approval of vaccines are the major factors hampering the growth of the influenza vaccines market.
Which is the leading vaccine type in the influenza vaccines market?
In terms of vaccine type, inactivated is estimated to dominate the market revenue share 2024.
Which are the major players operating in the influenza vaccines market?
CSL Seqirus, GlaxoSmithKline plc, Sanofi, AstraZeneca, FluGen Inc., Moderna Inc., Biocryst Pharmaceuticals Inc., CPL Biologicals Pvt. Ltd., CureVac AG, OSIVAX, Solaris Vaccines, Pfizer, Daiichi Sankyo, Bharat Biotech, and Sinovac Biotech are the major players.
Which region will lead the influenza vaccines market?
North America is expected to lead the influenza vaccines market.